Boston University scientists developed an AI model that predicts Alzheimer's-related protein levels using brain imaging and clinical data.
Key Details
- 1AI tool predicts presence of amyloid beta and tau proteins linked to Alzheimer's disease.
- 2Model incorporates brain scans, cognitive scores, genetics, and health history from 12,185 participants across seven cohorts.
- 3Tool provides location-specific brain information, unlike most blood tests.
- 4Successfully validated on a separate international cohort, showing robust predictive performance.
- 5Aims to enable earlier, cheaper, and more accessible Alzheimer's detection and staging.
- 6Published in Nature Communications on August 11, 2025.
Why It Matters
Accurate, cost-effective early detection of Alzheimer's using non-invasive imaging and AI could transform patient care and expedite selection for clinical trials. This approach highlights the expanding role of imaging AI in neurological disease diagnosis and management.
Source
EurekAlert
Related News
•EurekAlert
Study Warns: AI Alone Is Not Enough in Critical Healthcare Decisions
Evaluating both AI algorithms and human users is key for safe adoption in high-stakes healthcare settings, according to an Ohio State study.
•EurekAlert
AI Dramatically Improves Prediction of Delivery Timing from Ultrasound Images
Ultrasound AI's study validates advanced AI for predicting delivery timing using standard ultrasound images.
•EurekAlert
AI-Assisted Colonoscopies May Reduce Clinicians’ Detection Skills, Study Finds
Routine use of AI in colonoscopies linked to decreased skill in adenoma detection by clinicians without AI assistance.